B

아스테라시스

450950KOSDAQ

60.8 / 100

Reference Date: 2026-09-08

Financial Score26.5 / 40
News Sentiment21.3 / 25
Momentum3.0 / 20
Disclosure10.0 / 15
AI Analysis: the debt ratio is very low with excellent financial health but PBR raises overvaluation concerns. Declined 14.0% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Astersis is a company specializing in the production and sale of medical devices for aesthetic treatments, focusing on high-intensity focused ultrasound (HIFU) and radiofrequency (RF) technologies. Its flagship product, Liftera, stands out for reduced patient discomfort and enhanced efficacy, driving market differentiation. The company is expanding globally through new product development and international certifications, including FDA approval targeting 2025.

Number of Employees

88people

Average Salary

106.7M KRW

Score Calculation Basis

Detailed Financial Score

PER
21.08Industry Average 15.003.0Point

Higher than industry avg (caution)

PBR
4.24Industry Average 1.200.0Point

3.5x industry avg (risky)

ROE
27.74Industry Average 8.007.0Point

3.5x industry avg (excellent)

Debt Ratio
0.39Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2024~20258.5 / 10 points
Revenue Growth Rate
3.0 / 3

Avg ▲31.6% (1-year basis)

Operating Profit Growth Rate
3.0 / 3

Avg ▲55.9% (1-year basis)

ROE Trend
2.5 / 4

Avg ROE 34.2% (declining, 2yr)

Detailed News Sentiment

3 totalPositive 3Neutral 0Negative 0Average Sentiment Score 85

Detailed Momentum

52-week position1.0Point

Near 52w low (2%, downtrend)

Current 5,270Won52-week high 16,10052-week low 5,000
1-month return1.0Point

1m -14.03% (falling)

Volume trend1.0Point

Volume dry-up

Detailed Disclosure

1 totalPositive 0Neutral 1Negative 0
  • Neutral반기보고서 (2026.06)2026-08-14